A new function for the serine protease HtrA2 in controlling radiation‐induced senescence in cancer cells. Issue 6 (16th February 2022)
- Record Type:
- Journal Article
- Title:
- A new function for the serine protease HtrA2 in controlling radiation‐induced senescence in cancer cells. Issue 6 (16th February 2022)
- Main Title:
- A new function for the serine protease HtrA2 in controlling radiation‐induced senescence in cancer cells
- Authors:
- Hammer, Liat
Levin‐Salomon, Vered
Yaeli‐Slonim, Naama
Weiss, Moria
Dekel‐Bird, Naama P.
Olender, Tsviya
Porat, Ziv
Winograd‐Katz, Sabina
Savidor, Alon
Levin, Yishai
Bialik, Shani
Geiger, Benjamin
Kimchi, Adi - Abstract:
- Abstract : Radiation therapy can induce cellular senescence in cancer cells, leading to short‐term tumor growth arrest but increased long‐term recurrence. To better understand the molecular mechanisms involved, we developed a model of radiation‐induced senescence in cultured cancer cells. The irradiated cells exhibited a typical senescent phenotype, including upregulation of p53 and its main target, p21, followed by a sustained reduction in cellular proliferation, changes in cell size and cytoskeleton organization, and senescence‐associated beta‐galactosidase activity. Mass spectrometry‐based proteomic profiling of the senescent cells indicated downregulation of proteins involved in cell cycle progression and DNA repair, and upregulation of proteins associated with malignancy. A functional siRNA screen using a cell death‐related library identified mitochondrial serine protease HtrA2 as being necessary for sustained growth arrest of the senescent cells. In search of direct HtrA2 substrates following radiation, we determined that HtrA2 cleaves the intermediate filament protein vimentin, affecting its cytoplasmic organization. Ectopic expression of active cytosolic HtrA2 resulted in similar changes to vimentin filament assembly. Thus, HtrA2 is involved in the cytoskeletal reorganization that accompanies radiation‐induced senescence and the continuous maintenance of proliferation arrest. Abstract : Htra2, a mitochondrial serine protease that is a known regulator of apoptosis,Abstract : Radiation therapy can induce cellular senescence in cancer cells, leading to short‐term tumor growth arrest but increased long‐term recurrence. To better understand the molecular mechanisms involved, we developed a model of radiation‐induced senescence in cultured cancer cells. The irradiated cells exhibited a typical senescent phenotype, including upregulation of p53 and its main target, p21, followed by a sustained reduction in cellular proliferation, changes in cell size and cytoskeleton organization, and senescence‐associated beta‐galactosidase activity. Mass spectrometry‐based proteomic profiling of the senescent cells indicated downregulation of proteins involved in cell cycle progression and DNA repair, and upregulation of proteins associated with malignancy. A functional siRNA screen using a cell death‐related library identified mitochondrial serine protease HtrA2 as being necessary for sustained growth arrest of the senescent cells. In search of direct HtrA2 substrates following radiation, we determined that HtrA2 cleaves the intermediate filament protein vimentin, affecting its cytoplasmic organization. Ectopic expression of active cytosolic HtrA2 resulted in similar changes to vimentin filament assembly. Thus, HtrA2 is involved in the cytoskeletal reorganization that accompanies radiation‐induced senescence and the continuous maintenance of proliferation arrest. Abstract : Htra2, a mitochondrial serine protease that is a known regulator of apoptosis, was identified through an siRNA screen as a positive mediator of radiation‐induced senescence in cancer cells. Following irradiation, Htra2 enables continuous maintenance of proliferation arrest and cleaves the intermediate filament protein vimentin, leading to filament disassembly and cytoskeletal reorganization. … (more)
- Is Part Of:
- Molecular oncology. Volume 16:Issue 6(2022)
- Journal:
- Molecular oncology
- Issue:
- Volume 16:Issue 6(2022)
- Issue Display:
- Volume 16, Issue 6 (2022)
- Year:
- 2022
- Volume:
- 16
- Issue:
- 6
- Issue Sort Value:
- 2022-0016-0006-0000
- Page Start:
- 1365
- Page End:
- 1383
- Publication Date:
- 2022-02-16
- Subjects:
- cellular senescence -- HtrA2/Omi -- radiation therapy -- siRNA functional screen -- vimentin
Cancer -- Molecular aspects -- Periodicals
616.994005 - Journal URLs:
- http://www.journals.elsevier.com/molecular-oncology/ ↗
http://febs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)1878-0261/issues/ ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1002/1878-0261.13187 ↗
- Languages:
- English
- ISSNs:
- 1574-7891
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5900.817993
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21180.xml